2 NASH drugmakers have wildly different Mondays

2 NASH drugmakers have wildly different Mondays

Submitted by admin on November 25, 2019 - 10:11pm
Source: 
Biopharma Dive
News Tags: 
Intercept Pharmaceuticals
CymaBay Therapeutics
FDA
NASH
seladelpar
obeticholic acid
Headline: 
2 NASH drugmakers have wildly different Mondays
snippet: 

Shares of Intercept Pharmaceuticals rose on a positive FDA update, while CymaBay Therapeutics plummeted following a clinical trial setback.

Do Not Allow Advertisers to Use My Personal information